American Cancer Society (2013) Cancer Facts & Figures 2013. Atlanta: American Cancer Society.
Bailar 3rd, J. and E. M. Smith (1986) “Progress Against Cancer?” New England Journal of Medicine, 314(19):1226–1232. [Web of Science]
Bleyer, A. and H. G. Welch (2012) “Effect of Three Decades of Screening Mammography on Breast-Cancer Incidence,” New England Journal of Medicine, 367(21):1998–2005.
Chu, K. C., C. R. Smart and R. E. Tarone (1988) “Analysis of Breast Cancer Mortality and Stage Distribution by Age for the Health Insurance Plan Clinical Trial,” Journal of the National Cancer Institute, 80(14):1125–1132.
Citarda, F., G. Tomaselli, R. Capocaccia, S. Barcherini, M. Crespi and I. M. S. Group (2001) “Efficacy in Standard Clinical Practice of Colonoscopic Polypectomy in Reducing Colorectal Cancer Incidence,” Gut, 48(6):812–815.
Cohen, M. M. and J. M. Diamond (1986) “Medical Research: Are We Losing the War On Cancer?” Nature, 323(6088):488–489.
Connor, R. J., K. C. Chu and C. R. Smart (1989) “Stage-Shift Cancer Screening Model,” Journal of Clinical Epidemiology, 42(11):1083–1095.
Cutler, D. M. (2008) “Are We Finally Winning The War on Cancer?” The Journal of Economic Perspectives, 22(4):3–26. [Web of Science]
Epstein, S. S. (1990) “Losing the War Against Cancer: Who’s to Blame and What To Do About It,” International Journal of Health Services, 20(1):53–71.
German, R. R., A. K. Fink, M. Heron, S. L. Stewart, C. J. Johnson, J. L. Finch and D. Yin (2011) “The Accuracy of Cancer Mortality Statistics Based on Death Certificates in the United States,” Cancer Epidemiology, 35(2):126–131. [Web of Science]
Goldman, D. P., C. Gupta, E. Vasudeva, K. Trakas, R. Riley, D. Lakdawalla, D. Agus, N. Sood, A. B. Jena and T. J. Philipson (2013) “The Value of Diagnostic Testing in Personalized Medicine,” Forum for Health Economics and Policy, 16:S87–S99.
Howard, D. H., P. B. Bach, E. R. Berndt and R. M. Conti (2015) “Pricing in the Market for Anticancer Drugs,” Journal of Economic Perspectives, 29(1):139–162.
Lakdawalla, D. N., E. C. Sun, A. B. Jena, C. M. Reyes, D. P. Goldman and T. J. Philipson (2010) “An Economic Evaluation of the War on Cancer,” Journal of Health Economics, 29(3):333–346.
Leaf, C. (2004) “Why We’re Losing The War on Cancer (and How to Win It),” Fortune (European Edition), 149(5):42–55.
Lightwood, J. M. and S. A. Glantz (1997) “Short-term Economic and Health Benefits of Smoking Cessation Myocardial Infarction and Stroke,” Circulation, 96(4):1089–1096.
Mellman, I., G. Coukos and G. Dranoff (2011) “Cancer Immunotherapy Comes of Age,” Nature, 480(7378):480–489.
National Cancer Institute. Overview of the SEER Program. Retrieved May 2, 2014, from http://seer.cancer.gov/about/overview.html.
Pharmaceutical Research and Manufacturers of America (2013) 2013 Biopharmaceutical Research Industry Profile. Washington, DC: PhRMA.
Philipson, T., M. Eber, D. N. Lakdawalla, M. Corral, R. Conti and D. P. Goldman (2012) “An Analysis of Whether Higher Health Care Spending in the United States versus Europe is ‘worth it’ in the Case of Cancer,” Health Affairs (Millwood), 31(4):667–675. [Web of Science]
Seabury, S. A., D. P. Goldman, J. R. Maclean, J. R. Penrod and D. N. Lakdawalla (2012) “Patients Value Metastatic Cancer Therapy More Highly Than Is Typically Shown Through Traditional Estimates,” Health Affairs, 31(4):691–699. [Web of Science]
Shapiro, S., J. D. Goldberg and G. B. Hutchison (1974). “Lead Time in Breast Cancer Detection and Implications for Periodicity of Screening,” American Journal of Epidemiology, 100(5):357–366.
Sharma, P., K. Wagner, J. D. Wolchok and J. P. Allison (2011) “Novel Cancer Immunotherapy Agents with Survival Benefit: Recent Successes and Next Steps,” Nature Reviews Cancer, 11(11):805–812. [Web of Science]
Soneji, S. and J. Yang (2015) “New Analysis Reexamines The Value Of Cancer Care In The United States Compared To Western Europe,” Health Affairs 34(3):390–397. [Web of Science]
Sporn, M. B. (1996) “The War On Cancer,” The Lancet, 347(9012):1377–1381.
Sun, E., A. B. Jena, D. Lakdawalla, C. Reyes, T. J. Philipson and D. P. Goldman (2010) “The Contributions of Improved Therapy and Early Detection to Cancer Survival Gains, 1988-2000,” Forum for Health Economics and Policy, 13(2): DOI: 10.2202/1558-9544.1195. [Crossref]
Taylor Jr., D. H., V. Hasselblad, S. J. Henley, M. J. Thun and F. A. Sloan (2002). “Benefits of Smoking Cessation for Longevity,” American Journal of Public Health, 92(6):990–996.
US Department of Health and Human Services. (2013) Percentage of Adults Who Receive Colorectal Cancer Screening as Appropriate. Retrieved April 22, 2014, from https://healthmeasures.aspe.hhs.gov/measure/25.
Vanneman, M. and G. Dranoff (2012) “Combining Immunotherapy and Targeted Therapies in Cancer Treatment,” Nature Reviews Cancer, 12(4):237–251. [Web of Science]
Wickens, M. R. (1972) “A Note On The Use of Proxy Variables,” Econometrica, 759–761.
Winawer, S. J., A. G. Zauber, M. N. Ho, M. J. O’Brien, L. S. Gottlieb, S. S. Sternberg, J. D. Waye, M. Schapiro, J. H. Bond and J. F. Panish (1993) “Prevention of Colorectal Cancer by Colonoscopic Polypectomy,” New England Journal of Medicine, 329(27):1977–1981.